IPP Bureau
Royal Sense launches stergic dengue IgG/IgM rapid test
By IPP Bureau - August 25, 2024
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%
By IPP Bureau - August 25, 2024
BioIVT acquires ZenBio
By IPP Bureau - August 25, 2024
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
BI Sky Global successfully completes FDA MoCRA registration
By IPP Bureau - August 25, 2024
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Fasenra approved in China for the treatment of severe eosinophilic asthma
By IPP Bureau - August 25, 2024
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
By IPP Bureau - August 24, 2024
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
BioAge appoints former GSK CEO Jean-Pierre Garnier as Chair of its Board of Directors
By IPP Bureau - August 23, 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Pfizer and BioNTech receive FDA authorization for Omicron KP.2-adapted Covid-19 Vaccine
By IPP Bureau - August 23, 2024
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
Roche responds to WHO’s declaration of health emergency due to mpox outbreak
By IPP Bureau - August 23, 2024
Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants
Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
By IPP Bureau - August 23, 2024
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Sun Pharma introduces STARIZO in India for skin infections
By IPP Bureau - August 23, 2024
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Novartis and Versant to form biotech venture Borealis Biosciences
By IPP Bureau - August 23, 2024
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
By IPP Bureau - August 23, 2024
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
Wanbury receives EIR from FDA for Patalganga facility
By IPP Bureau - August 23, 2024
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
HearClear partners with Neuberg Diagnostics to create integrated hearing care ecosystem
By IPP Bureau - August 23, 2024
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
